| Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in Southern Italian women with polycystic ovary syndrome. | |
| | |
MedLine Citation:
|
PMID: 20229450 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A major component of the polycystic ovary syndrome (PCOS) is the insulin resistance. Only a few studies have evaluated the IRS-1 polymorphism at codon 972, sometimes in the absence of a control group, and with great variability in frequency (0-23% in PCOS vs. 0-17% in controls), and with no unequivocal relationships between the polymorphism and clinical or biochemical indexes. The aim of the work was to evaluate the frequency of the IRS-1 polymorphism at codon 972 in PCOS, and correlate it to clinical and biochemical indexes. We assessed the rs 1801278 polymorphic variant in the IRS-1 gene (Gly972Gly=wild-type; Gly972Arg=heterozygosity; Arg972Arg=homozygosity) in genomic DNA by restriction fragment length polymorphism. The study was conducted at an academic medical center with the participation of 65 women with PCOS and 27 age-matched healthy women (controls). Compared to controls, Gly972Arg was very frequent in PCOS (77% vs. 18%, p<0.0001); one PCOS woman was homozygous. Compared to wild-type PCOS, heterozygous PCOS women had only three significantly different indexes: higher fasting insulin, insulin resistance index, and lower 120 min OGTT glucose. Moreover, in the correlation analysis between any two clinical or biochemical variables, the Pearson's correlation coefficients were frequently of different magnitude in heterozygous PCOS versus wild-type PCOS. Overall, heterozygous PCOS had a greater number of statistically significant relationships between different clinical, metabolic and hormonal indexes: 44 direct and 9 inverse versus 6 and 3, respectively. The IRS-1 Gly972Arg has the highest frequency reported world-wide for PCOS women. This variant is associated with insulin resistance and higher fasting insulin in PCOS women. |
| | |
Authors:
|
M A Pappalardo; G T Russo; A Pedone; A Pizzo; I Borrielli; G Stabile; A C Artenisio; A Amato; M Calvani; D Cucinotta; F Trimarchi; S Benvenga |
Publication Detail:
|
Type: Journal Article Date: 2010-03-12 |
Journal Detail:
|
Title: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme Volume: 42 ISSN: 1439-4286 ISO Abbreviation: Horm. Metab. Res. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-01 Completed Date: 2010-09-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0177722 Medline TA: Horm Metab Res Country: Germany |
Other Details:
|
Languages: eng Pagination: 575-84 Citation Subset: IM |
Copyright Information:
|
(c) Georg Thieme Verlag KG Stuttgart . New York. |
Affiliation:
|
Sezione di Endocrinologia, Dipartimento Clinico Sperimentale di Medicina e Farmacologia, Università di Messina, Messina, Italy. mapp20@libero.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Body Mass Index Case-Control Studies Codon / genetics* Female Genetic Association Studies Heterozygote Humans Insulin Receptor Substrate Proteins / genetics* Italy Ovary / ultrasonography Polycystic Ovary Syndrome / blood, genetics*, ultrasonography Polymorphism, Single Nucleotide / genetics* Triglycerides / blood Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Codon; 0/Insulin Receptor Substrate Proteins; 0/Triglycerides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sport-medical Aspects Concerning Asian Martial Arts Aikid?? and Ving Tsun.
Next Document: Multiple Aneurysms of Intracranial Arteries in Neurofibromatosis Recklinghausen Type 1.